Long-term low molecular weight heparin protection during pregnancy for the recurrent fetal loss
Recurrent fetal loss affects 1 to 5% women of the fertile age all over the world. Pathogenesis of recurrent early or late fetal loss remains unclear and therefore the LMHW administration during pregnancy has not been sorted out so far. Our trial deals with a cohort of 51 pregnant women with recurrent fetal loss in their personal history treated by long-term administration of LMWHs which was compared with a cohort of healthy women LMWHs untreated. 91% effectiveness of a long-term LMWH protection means in fact 43 liveborn babies delivered without any complications during pregnancy and delivery to 47 women - 30 of these women were primiparas.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2008 |
|---|---|
| Erschienen: |
2008 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
Ceska gynekologie - 73(2008), 5 vom: 15. Okt., Seite 278-83 |
| Sprache: |
Tschechisch |
|---|
| Weiterer Titel: |
Průbeh tehotenství pri dlouhodobém podávání nízkomolekulárního heparinu pro opakované tehotenské ztráty |
|---|
| Beteiligte Personen: |
Hajsmanová, Z [VerfasserIn] |
|---|
| Themen: |
Anticoagulants |
|---|
| Anmerkungen: |
Date Completed 27.01.2009 Date Revised 06.12.2016 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM185440452 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM185440452 | ||
| 003 | DE-627 | ||
| 005 | 20231223172506.0 | ||
| 007 | tu | ||
| 008 | 231223s2008 xx ||||| 00| ||cze c | ||
| 028 | 5 | 2 | |a pubmed24n0618.xml |
| 035 | |a (DE-627)NLM185440452 | ||
| 035 | |a (NLM)19110954 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a cze | ||
| 100 | 1 | |a Hajsmanová, Z |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Long-term low molecular weight heparin protection during pregnancy for the recurrent fetal loss |
| 246 | 3 | 3 | |a Průbeh tehotenství pri dlouhodobém podávání nízkomolekulárního heparinu pro opakované tehotenské ztráty |
| 264 | 1 | |c 2008 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 27.01.2009 | ||
| 500 | |a Date Revised 06.12.2016 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Recurrent fetal loss affects 1 to 5% women of the fertile age all over the world. Pathogenesis of recurrent early or late fetal loss remains unclear and therefore the LMHW administration during pregnancy has not been sorted out so far. Our trial deals with a cohort of 51 pregnant women with recurrent fetal loss in their personal history treated by long-term administration of LMWHs which was compared with a cohort of healthy women LMWHs untreated. 91% effectiveness of a long-term LMWH protection means in fact 43 liveborn babies delivered without any complications during pregnancy and delivery to 47 women - 30 of these women were primiparas | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Heparin, Low-Molecular-Weight |2 NLM | |
| 700 | 1 | |a Slechtová, J |e verfasserin |4 aut | |
| 700 | 1 | |a Sigutová, P |e verfasserin |4 aut | |
| 700 | 1 | |a Ulcová-Gallová, Z |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Ceska gynekologie |d 1997 |g 73(2008), 5 vom: 15. Okt., Seite 278-83 |w (DE-627)NLM075127520 |x 1210-7832 |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2008 |g number:5 |g day:15 |g month:10 |g pages:278-83 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 73 |j 2008 |e 5 |b 15 |c 10 |h 278-83 | ||